
Nurorise P 750mcg/75mg Tablet SR
Marketer
DRS Alexia Pharma Pvt Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Nurorise P 750mcg/75mg Tablet SR
Prenox 750mcg/75mg Extended-Release Tablets are a prescription medication for managing neuropathic pain. Its mechanism involves modulating nerve cell calcium channels to reduce pain signals. This medication also offers neuroprotective effects, promoting nerve fiber health and repair. Prenox 750mcg/75mg Extended-Release Tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain therapeutic drug levels. Adhere strictly to your doctor's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without prior consultation with your physician. Commonly reported side effects include upper respiratory infection, increased appetite, elevated mood, tremors, visual blurring, dry mouth, dizziness, and somnolence. Refrain from operating machinery or engaging in tasks demanding concentration until the medication's effects are understood. These side effects are typically mild and resolve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Complete disclosure of all other medications being taken is crucial, as interactions can affect Prenox's efficacy or action. Notify your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Uses of Nurorise P 750mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Nurorise P 750mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nurorise P 750mcg/75mg Extended-Release Tablet can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Nurorise P 750mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Nurorise P 750mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Nurorise P 750mcg/75mg Sustained-Release tablet can be consumed with or without food, although consistent timing is recommended.
How Nurorise P 750mcg/75mg Tablet SR works:
Each Nurorise P 750mcg/75mg sustained-release tablet combines methylcobalamin, a vitamin B variant crucial for myelin production (the protective sheath around nerves), and pregabalin, an alpha-2-delta ligand. Methylcobalamin aids nerve repair and regeneration, while pregabalin's action on nerve cell calcium channels reduces pain signaling. This dual mechanism effectively targets and alleviates neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nurorise P 750mcg/75mg SR tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Nurorise P 750mcg/75mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Nurorise P 750mcg/75mg tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Nurorise P 750mcg/75mg SR tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Nurorise P 750mcg/75mg Tablet SR. Dosage modification of Nurorise P 750mcg/75mg Tablet SR might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver conditions can likely use Nurorise P 750mcg/75mg Tablet SR without safety concerns. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Nurorise P 750mcg/75mg Tablet SR :
Should you forget a dose of Nurorise P 750mcg/75mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nurorise P 750mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |
